SCI Files Patents Relating to Production of Human Motor Neurons and Progenitors
News May 02, 2006
Stem Cell Innovations, Inc. has filed a patent application protecting the differentiation of its proprietary human pluripotent stem cells (PCs) into neural progenitor cells and purified populations of motor neurons.
These cells will initially be used in the Company's core drug discovery and toxicology platform. The Company is also exploring therapeutic applications of these cells.
Dr. James Kelly, CEO of Stem Cell Innovations, Inc, stated, "These cells have significant potential in both drug discovery and cell therapies to treat diseases such as ALS, Parkinson's, Huntington's, Multiple Sclerosis, and Spinal Cord Injury."
"Obtaining and protecting neural progenitor cells, as well as purified populations of motor neurons from our PCs, is a significant step for the company."
Kelly added, "We are already in discussions with companies that have expressed interest in these cells."
T Cells Attack and Kill Dopamine-Producing Cells in Parkinson's diseaseNews
Researchers in Germany discover a potential new target for treating Parkinson's diseaseREAD MORE
The “Traffic Cop” Protein Which Gives Progenitor Cells Permission to DifferentiateNews
Knowledge of this dictating protein may help find therapies for the injured brain and affect glial tumor cell researchREAD MORE
Regenerative Medicine Meets Clever Engineering to Accommodate Bone GraftsNews
Personalized bone grafts developed to repair bone defects from disease or injuryREAD MORE
5th edition of the International Conference Clinical Oncology and Molecular Diagnostics
Jun 17 - Jun 18, 2019